AVM
Arch Venture Management Portfolio holdings
AUM
$299M
This Quarter Return
-3.71%
1 Year Return
-19.47%
3 Year Return
-31.35%
5 Year Return
–
10 Year Return
–
AUM
$154M
AUM Growth
+$154M
(-4.9%)
Cap. Flow
+$6.71M
Cap. Flow
% of AUM
4.36%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Gossamer Bio
GOSS
|
$6.71M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EQRX
1
DELISTED
EQRx, Inc. Common Stock
EQRX
| $80.7M | 52.39% |
36,335,375
| – | – |
|
|
VERV
2
DELISTED
Verve Therapeutics
VERV
| $26.6M | 17.3% |
2,008,809
| – | – |
|
3
Erasca
ERAS
$445M
| $21.8M | 14.15% |
11,055,554
| – | – |
|
4
Denali Therapeutics
DNLI
$2.23B
| $14.3M | 9.3% |
693,749
| – | – |
|
|
5
Gossamer Bio
GOSS
$562M
| $6.71M | 4.36% |
+8,055,916
| New | +$6.71M |
|
|
UBX
6
DELISTED
Unity Biotechnology
UBX
| $2.41M | 1.57% |
1,004,817
| – | – |
|
|
OMIC
7
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $1.45M | 0.94% |
3,798,926
| – | – |
|